These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 19466750

  • 1. Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.
    Saussede-Aim J, Matera EL, Ferlini C, Dumontet C.
    Cell Motil Cytoskeleton; 2009 Jul; 66(7):378-88. PubMed ID: 19466750
    [Abstract] [Full Text] [Related]

  • 2. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 4. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K, Banerjee S, Saxena N, Banerjee SK.
    Int J Oncol; 2003 Mar 01; 22(3):609-14. PubMed ID: 12579315
    [Abstract] [Full Text] [Related]

  • 5. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
    Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, Toi M.
    Oncogene; 2005 Jun 30; 24(28):4531-9. PubMed ID: 15806142
    [Abstract] [Full Text] [Related]

  • 6. Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
    Jansen GH, Franke HR, Wolbers F, Brinkhuis M, Vermes I.
    Climacteric; 2008 Aug 30; 11(4):315-21. PubMed ID: 18645697
    [Abstract] [Full Text] [Related]

  • 7. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 30; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 8. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM, Korach KS.
    Mol Endocrinol; 2003 May 30; 17(5):792-803. PubMed ID: 12586845
    [Abstract] [Full Text] [Related]

  • 9. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP.
    Anticancer Res; 2003 May 30; 23(2B):1455-60. PubMed ID: 12820409
    [Abstract] [Full Text] [Related]

  • 10. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B.
    Mol Cell Endocrinol; 2011 May 16; 338(1-2):28-37. PubMed ID: 21356271
    [Abstract] [Full Text] [Related]

  • 12. Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and antiestrogens.
    Funk JL, Wei H.
    Biochem Biophys Res Commun; 1998 Oct 29; 251(3):849-54. PubMed ID: 9790998
    [Abstract] [Full Text] [Related]

  • 13. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
    Hurd C, Dinda S, Khattree N, Moudgil VK.
    Oncogene; 1999 Jan 28; 18(4):1067-72. PubMed ID: 10023683
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 17. Differences in morphology and cytoskeleton of MCF-7 and MX-1 cells after therapy with OH-tamoxifen and the pure estrogen antagonist ZM 182780. An immunofluorescence and scanning electron microscopic study.
    Ehlers EM, Schubert C.
    Ann Anat; 1999 May 06; 181(3):231-6. PubMed ID: 10363104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.